De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal
Conditions: Single Transplant; 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS Intervention: Drug: Immunosuppressive Sponsor: University of Rome Tor Vergata Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Liver | Liver Transplant | Metabolic Syndrome | Research | Transplant Surgery | Transplants | Urology & Nephrology